KLRK1 and cancer: To validate them, the NKG2D gene was inserted into T cells to express the corresponding CAR of NKG2D allowing NKG2D‐engineered CAR‐T cells to bind with MDA‐MB‐231 cancer cells and induce lysis (Figure6a).